AETHLON MEDICAL INC

For the period ended Mar 31, 2025. Filed Jun 26, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Jun 26, 2025

AEMD$5.49+0.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	March 31,
	2025	2024
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$5,501,261	$5,441,978
Deferred offering costs	–	277,827
Prepaid expenses and other current assets	448,539	505,983
TOTAL CURRENT ASSETS	5,949,800	6,225,788
Property and equipment, net	676,220	1,015,229
Operating lease right-of-use asset	601,846	883,054
Patents, net	550	1,100
Restricted cash	97,813	87,506
Deposits	33,305	33,305
TOTAL ASSETS	$7,359,534	$8,245,982
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable	$534,524	$777,862
Due to related parties	579,565	546,434
Operating lease liability, current portion	313,033	290,565
Other current liabilities	472,164	215,038
TOTAL CURRENT LIABILITIES	1,899,286	1,829,899
Operating lease liability, less current portion	336,718	649,751
TOTAL LIABILITIES	2,236,004	2,479,650
COMMITMENTS AND CONTINGENCIES (Note 8)	–	–
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 60,000,000 shares authorized at March 31, 2025 and 2024; 2,585,239 and 328,728 shares issued and 2,010,739 and 328,728 outstanding at March 31, 2025 and 2024, respectively	2,586	329
Additional paid-in capital	173,092,894	160,339,671
Accumulated other comprehensive loss	(17,133)	(6,940)
Accumulated deficit	(167,954,817)	(154,566,728)
TOTAL STOCKHOLDERS’ EQUITY	5,123,530	5,766,332
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$7,359,534	$8,245,982

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.